Table 5. In Vitro Efficacy of IQP-0410 Dermal Films.
Time (days) | Antiviral Efficacy | Antiviral Efficacy |
---|---|---|
CEM-SS/HIV-1IIIB | PBMC/HIV-1BaL | |
EC50 (nM) | EC50 (nM) | |
1 | 1.71 ± 0.01 | 1.65 ± 0.55 |
2 | 1.99 ± 0.16 | 0.82 ± 0.26 |
3 | 2.56 ± 0.40 | 0.58 ± 0.03 |
Time (days) | Antiviral Efficacy | Antiviral Efficacy |
---|---|---|
CEM-SS/HIV-1IIIB | PBMC/HIV-1BaL | |
EC50 (nM) | EC50 (nM) | |
1 | 1.71 ± 0.01 | 1.65 ± 0.55 |
2 | 1.99 ± 0.16 | 0.82 ± 0.26 |
3 | 2.56 ± 0.40 | 0.58 ± 0.03 |